ImmusanT rakes in funding
Cambridge, Massachusetts-based ImmusanT Inc, a developer of treatments for celiac disease, has secured an undisclosed amount of funding. The investor was JDRF T1D Fund.
11 September 2018•1 min read
Cambridge, Massachusetts-based ImmusanT Inc, a developer of treatments for celiac disease, has secured an undisclosed amount of funding. The investor was JDRF T1D Fund.
